The benefits of transitioning from paper-based to paperless batch record management

29 Oct 2019

Free webinar to discuss the benefits of a collaborative approach to implementing an electronic batch record platform.

Lonza will host a free 60-minute webinar (on 12 November) during which Nephron Pharmaceuticals will explain its decision to take a paperless approach to batch record management.

The benefits of transitioning from paper-based to paperless batch record management

Nephron will also discuss how its close relationship with Lonza allowed for a rapid implementation of Lonza’s MODA-ES electronic batch record (EBR) Platform in just 9 months, leading to increased operational efficiency and expanded product lines.

Recording batch data is an essential part of the pharmaceutical manufacturing process. However, the wealth of information generated by each batch is traditionally collected using paper-based workflows, which are inherently resource intensive, time consuming and can negatively impact the time-to-market for new therapeutics. As such, pharmaceutical manufacturers are increasingly turning to paperless EBR solutions to eliminate these challenges.

In the webinar titled “Paper to EBR in 9 Months: How a Strong Collaboration Leads to Project Success,” Bryan Beck, Vice President for Automation and Information Technology at Nephron Pharmaceuticals, will discuss the following topics:

  • Why Nephron implemented an EBR Platform.
  • How the collaborative approach to expedited implementation resulted in an EBR platform with a user-friendly and configurable design.
  • How the implementation of Lonza’s MODA-ES EBR Platform at Nephron has enabled compliance with regulatory requirements while driving growth and operational efficiency.
  • Paper to EBR in 9 Months: How a Strong Collaboration Leads to Project Success

    Speaker: Bryan Beck; Moderator: Geoffrey Swafford, Senior Manager for MODA Implementation at Lonza Bioscience Solutions

  • Tuesday, 12 November 2019
  • 8 AM PST (Los Angeles)
  • 11 AM EST (New York)
  • 4 PM GMT (London)
  • 5 PM CET (Berlin)
  • Read More

    Related news

    iNova Pharmaceuticals announces the launch of iPitch 2020

    iNova Pharmaceuticals announces the launch of iPitch 2020

    3 Jul 2020

    Following on from the success of the inaugural iPitch launch in 2019, iNova Pharmaceuticals is delighted to announce the launch of a new round of iPitch challenges for 2020.

    Read more 
    Ajinomoto introduces fast track platform for drug product manufacturing

    Ajinomoto introduces fast track platform for drug product manufacturing

    30 Jun 2020

    AJILITY is designed to speed novel or existing therapeutics from development to manufacturing and into the clinic.

    Read more 
    CPhI Worldwide to transform into Festival of Pharma digital experience

    CPhI Worldwide to transform into Festival of Pharma digital experience

    30 Jun 2020

    The 10-day event will feature an interactive digital marketplace for sourcing products and services, enhanced matchmaking for connecting with new and existing partners, and world-renowned speakers.

    Read more 
    Catalent expands beauty and plant-based consumer health softgel capabilities

    Catalent expands beauty and plant-based consumer health softgel capabilities

    30 Jun 2020

    Two company sites - one in Canada, the other in Brazil - receive new softgel encapsulation lines to service local customer demand.

    Read more 
    Stevanato Group pledges to provide glass vials for potential COVID-19 vaccines

    Stevanato Group pledges to provide glass vials for potential COVID-19 vaccines

    29 Jun 2020

    The company agrees to provide CEPI with 100 million glass vials, which can store 20 doses per vial (2 billion doses in total).

    Read more 
    PCI Pharma Services completes biotech Center of Excellence

    PCI Pharma Services completes biotech Center of Excellence

    29 Jun 2020

    The global outsourcing solutions provider is also set to expand its biotech capabilities in Europe.

    Read more 
    DuPont's seaweed-based soft capsule ingredient gains non-GMO certification

    DuPont's seaweed-based soft capsule ingredient gains non-GMO certification

    29 Jun 2020

    SeaGel offers drug and dietary supplement manufacturers an animal-free and sustainable alternative to traditional soft capsules.

    Read more 
    Gilead pencils in potential buyout of Pionyr Immunotherapeutics

    Gilead pencils in potential buyout of Pionyr Immunotherapeutics

    23 Jun 2020

    Pionyr's "promising, novel biology" could represent a major increase in Gileads's cancer pipeline.

    Read more 
    CordenPharma & Moderna extend lipid supply agreement for Moderna’s coronavirus vaccine

    CordenPharma & Moderna extend lipid supply agreement for Moderna’s coronavirus vaccine

    23 Jun 2020

    The amended manufacturing agreement, which originally specified CordenPharma facilities Switzerland, now extends to the CDMOs France and US sites.

    Read more 
    TraceLink announces results from FDA DSCSA Pilot Program

    TraceLink announces results from FDA DSCSA Pilot Program

    23 Jun 2020

    Key findings demonstrate the value of network solutions to secure and digitalize the pharmaceutical supply chain.

    Read more